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Abstract 
 
Objective 
Patient-directed knowledge tools are designed to engage patients in dialogue or deliberation, to 
support patient decision-making or self-care of chronic conditions. However, an abundance of 
these exists. The tools themselves and their purposes are not always clearly defined; creating 
challenges for developers and users (professionals, patients). The study’s aim was to develop a 
conceptual framework of patient-directed knowledge tool types. 
 
Methods 
A face-to-face evidence-informed consensus meeting with 15 international experts. After the 
meeting, the framework went through two rounds of feedback before informal consensus was 
reached. 
 
Results 
A conceptual framework containing five patient-directed knowledge tool types was developed. 
The first part of the framework describes the tools’ purposes and the second focuses on the 
tools’ core elements.  
 
Conclusion 
The framework provides clarity on which types of patient-directed tools exist, the purposes they 
serve, and which core elements they prototypically include. It is a working framework and will 
require further refinement as the area develops, alongside validation with a broader group of 
stakeholders.  
 
Practice implications 
The framework assists developers and users to know which type a tool belongs, its purpose and 
core elements, helping them to develop and use the right tool for the right job.  
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1.0 Introduction 
In 1996, Sackett et al described evidence-based medicine as integrating “the best external 
evidence with individual clinical expertise and patients' choice”, and Charles et al tried in 1997 
to define shared (treatment) decision-making (1, 2). Both heralded the more formal recognition 
of patient engagement. The WHO defines patient engagement as (the process of building) the 
capacity of patients, families, carers, as well as healthcare providers, to facilitate and support 
the active involvement of patients in their own care, in order to enhance safety, quality and 
people-centeredness of healthcare service delivery (3).  
 
In the past, patient engagement might have been primarily a moral-ethical imperative (4), but 
this engagement is also associated with numerous beneficial outcomes such as improved 
knowledge, satisfaction and self-management and reduced decisional conflict (5-9). Moreover, 
involving the patient is important because physicians may recommend treatments that they 
would not have chosen themselves (10), and physicians are mostly not adept at predicting what 
their patients want (11, 12). These and other reasons to engage patients in decisions about care 
have led to the development of a range of knowledge tools (13, 14).  
 
Overall, there exists an abundance of tools to engage patients in decision-making and 
contribute to patient-centred care. Examples of knowledge tools are clinical practice guidelines 
(CPG), protocols, patient decision aids (PDAs) and patient education materials (15-17). 
Knowledge tools distil and synthesize the highest quality knowledge and research (18). Patient-
directed knowledge tools are aimed directly at the patient (family members and carers), with the 
goal to engage patients in dialogue or deliberation during a clinical encounter, or to support 
and/or improve patient decision-making which may or may not take place during a clinical 
encounter (13). The ultimate goal is to contribute to safer and higher quality healthcare 
(delivery). However, these types of tools are frequently ill defined (16, 19, 20). Moreover, lack of 
clarity on development, content, and purpose has likely contributed to poor uptake (21-24).  
 
Several streams of work have contributed to the development of this area. These include 
development of specific quality criteria for certain tools (such as PDAs, leading to IPDAS, the 
International Patient Decision Aid Standards) (25-28) as well as frameworks and taxonomies on 
patient involvement. The purpose of IPDAS is to enhance the quality and effectiveness of 
patient decision aids by establishing a shared evidence-informed framework (29-31). IPDAS 
does not consider other patient-directed knowledge tools. Several frameworks related to 
decision support tools have been developed (32). O’Connor et al developed a decision support 
framework to develop a specific PDA, concentrating on determinants of decisions leading to the 
Ottawa Decision Support Framework (33, 34).  Another example is a taxonomy of outcomes 
developed by the Cochrane Consumers & Communication Group (CCCG) which can be used 
by researchers and others to conceptually map the range of outcomes, at different levels of 
health care, that might be relevant when assessing different forms of communication (such as 
shared decision making) (35).  
 
Existing frameworks tend to focus on PDAs, and the CCCG taxonomy has a far broader scope 
than just patient-directed knowledge tools. The aim of our study was therefore, building on 
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existing work, to develop a conceptual framework of patient-directed knowledge tools (36). Our 
objective was to create a framework that would identify existing patient-directed tool types, 
allows organization of these types of tools by their purpose(s) and describes their core 
elements. The framework is intended primarily for tool developers, and possibly also for those 
who commission the development of tools, healthcare professionals and policy makers. It 
should help developers to identify where there is a gap or need for a tool to be developed, and 
how such a tool may best make information, knowledge and decision support available to 
patients (37). 
 
 
2.0 Methods 
We used a two-day consensus meeting with international experts. We are not aware of 
standards for reporting a consensus-based meeting. Instead, we followed the Standards for 
Reporting Qualitative Research (SRQR) as closely as possible, when writing the manuscript 
(38). 
 
To arrive at a conceptual framework of patient-directed knowledge tool types to engage patients 
and support patient decision making within a short time frame, the initiators (TVDW, DD) and 
chair (JG) decided that a two-day, face-to-face meeting with experts was the most optimal 
design. We followed a consensus-based process based on a written meeting protocol (see 
annex A) (39-41). The meeting was audio-recorded, DD took. JG and TVDW made field notes. 
The meeting took place in February 2016, in Leiden, the Netherlands.  
 
The participants were purposefully sampled from the Guideline International Network (GIN), 
International Shared Decision Making network (ISDM) and the professional networks of the 
initiators. The participants worked in different domains of knowledge (transfer), implementation 
and decision support, e.g. as tool developers, implementers or implementation researchers, 
decision making researchers, or practitioners. The aim was to have representation from a range 
of countries, individuals with various professional backgrounds, and patients (see annex B). 
There were two groups of participants; those who participated face-to-face in the group meeting 
and those who joined remotely for the conference call with the large group, or via e-mail. 
 
During the preparatory phase the participants received a list with relevant literature (see annex 
C). This list included participants’ key articles – suggested by TVDW – and its aim was to 
achieve a common ground between the participants. They also received a list with possible 
knowledge tool types to be discussed (see annex D). The list was the result of a scoping review 
undertaken by initiator DD. The meeting protocol was also shared with the participants in this 
phase (see annex A) (42). The experts were asked to add missing literature, review the 
proposed tools and comment on the protocol. If the experts had queries on the provided tools, 
DD and TVDW provided information to clarify these issues, copying all participants. 
 
The meeting consisted of nine steps (see table 1). In step 1, the face-to-face participant group 
discussed and came to agreement on the scope of the meeting, and the intended final 
product(s). In step 2, they discussed the list with tool types (annex D) to ensure that all 
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participants present in the face-to-face meeting were familiar with the tools and their definitions, 
and, if not, described the tool, and verified that the list was complete. After agreeing on the 
scope and the tool list, the participants broke up into two groups to sort the tools: which ones 
were to be included in the framework and which ones not, using the definition of the patient-
directed knowledge tool (step 3). The two groups presented and discussed each other’s 
findings, and agreed on a list of preliminary tools to be included. Based on this list, the two 
groups independently identified purposes of the tools, taking the discussed and agreed upon 
standard definitions from step 2 into account (step 4). The outcomes of both groups were 
presented and discussed. This resulted in a first draft of the framework stating the preliminary 
included tools and their purposes. In step 5, the participants were split up in the two same 
groups, and were asked – using their research and practice knowledge – to identify core 
elements of the included tools. Once more, the findings of both groups were presented, 
discussed, and categorised leading to the second draft of the framework stating tool types, 
purposes and core elements. 
 
Dividing the participants into two groups facilitated involving all participants, and avoiding any 
individual dominating the group. When there was disagreement the participants discussed the 
issue until consensus was reached.  
 
The next step involved compiling the discussions and findings during a longer break and sent 
via email – together with the second draft of the framework – to participants taking part via a 
telephone conference at the end of day 1. The first day’s discussions and findings were 
presented by DD to the participants calling in, and the other participants in the room. The former 
participants were given the opportunity to ask clarifying questions, and propose/suggest 
additional tools, purposes, and core elements (step 6). The draft framework was adapted with 
the input of the remote participants. A summary of the discussions and findings, together with 
the latest draft framework, were sent via email to participants SH and RR in Australia who could 
not participate in the teleconference. They would add their knowledge and input during the night 
(step 7), so that it could be discussed during day 2 of the meeting.    
 
Day 2 was dedicated to fine-tuning the draft framework. Therefore, in step 8 the chair (JG) 
reviewed the possible tools and purposes with the participants to ensure that these were correct 
and complete, and if all agreed, confirming the purpose(s) for each tool. This exercise was 
repeated for the core elements (step 9). These steps resulted in the final draft of the framework 
as developed during the meeting.  
 
Step What Who 
1 Discussed and agreed on the scope.  Participants in face-to-face 
meeting 
2 Discussed the list with tool types to familiarize with the tools and their 
definitions, and if the list was complete.  
Participants in face-to-face 
meeting 
3 Including and excluding tools for the framework in subgroups; outcomes 
presented and discussed with whole group.  
Participants face-to-face 
meeting  
4 Identified purposes of the tools in subgroups; discussed outcomes 
presented and discussed with whole group.   
Participants face-to-face 
meeting  
5 Identified core elements of the included tools. Participants face-to-face 
meeting 
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→ First draft of conceptual framework ready 
6 Presented and discussed draft framework; additional tools, purposes, 
and core elements suggested. 
Teleconference 
participants  
→ Second draft of conceptual framework ready 
7 Received input on draft framework via email.  Australian participants 
8 Fine-tuning: reviewed & confirmed the possible tool types and purposes 
to ensure that these were correct and complete.  
Participants face-to-face 
meeting 
9 Fine-tuning: reviewed & confirmed the core elements to ensure that 
these were correct and complete.  
Participants face-to-face 
meeting 
→ Final draft of the framework as developed during the meeting 
 
Table 1: Step-by-step process during two-day consensus meeting 
 
TVDW and DD finalized the draft framework based on the minutes, field notes and recorded 
data. This also entailed comparing the draft framework with existing frameworks and 
taxonomies. The comparison was done for two reasons: first, to compare language and 
terminology used, and second, to establish where the frameworks differed or were alike. 
The draft framework was distributed in the form of a scientific manuscript to the participants for 
final feedback. It took one face-to-face session with JG and two rounds by email with all co-
authors before consensus was reached on the draft framework. 
 
All participants completed a declaration of interests. The initiators and chair proposed how to 
deal with the declared interests. This was discussed and decided upon at the start of the 
meeting. The plenary parts of the meeting were audio-recorded and DD took minutes during 
both days. Furthermore, DD and TVDW compared the minutes and field, and adjusted them if 
needed. The adjusted minutes – checked against the recorded data – were shared afterwards 
with the participants for comments.  
 
 
3.0 Results  
The actual meeting was not as linear as described in the meeting protocol and methods section. 
It turned out to be an iterative process where discussions on tools and purposes lead to core 
elements and vice versa, but also prompting new or dismissed tool types to be (re-)included, 
such as care maps.  
 
Meeting participants included the moderator (TVDW), secretary (DD), and 13 experts; nine 
participants attended in person (JG (chair), TA, GE, SF, LK, NS, DS, AS, ST), and four (MA, 
AG, FL, PV) additionally took part in the teleconference. Two participants (SH, RR) took part via 
email (see annex B). All participants took part in the iterative discussions by email afterwards to 
finalize the manuscript with the draft framework. 
 
Step 1 was to select the tool types to be used when building the framework. Inclusion criteria 
were:  
• Main target group are patients (family, care givers); 
• Content driven instead of process oriented; 
• Tool type globally known and used; 
• Fits within the definition of the patient-directed knowledge tool (or not a knowledge tool). 
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Based on the outcomes of the subgroups and decisions on these with all participants, we 
excluded seven tool types (not aimed directly at the patient) from the original list of 11 and 
added one tool perceived to be aimed at the patient directly but not of the list provided (see 
table 2). While discussing the selection with the whole group, we decided to split patient 
decision aids (PDA) into an encounter patient decision aid (ePDA) and an ‘independent’ PDA, 
leading to six tools. This distinction is important because the patients will use the former while 
talking with a healthcare professional and the latter independently, pre- or post-encounter. Tools 
such as action plans and decision guides were excluded because they concentrate on ‘how’ 
(process), and less on ‘what’ (knowledge). Decision coaching tools were deemed out of scope 
as well because these are aimed at the patient’s coach, rather than primarily at the patient. 
During the telephone conference two tool types – question prompt list and decision box – were 
added because they support involving the patient in the care process, leading to a total of eight 
tools (see table 2 and annexes F and D).    
 
# Tool type Included, excluded and remarks 
1 Decision tree Preliminary included from list during face-to-face meeting 
2 Summary of clinical practice guideline Preliminary included from list during face-to-face meeting 
 Patient decision aid (PDA) 
Preliminary included from list during face-to-face meeting,  
and split into: 
3 - Encounter patient decision aid (ePDA) 
4 - Independent patient decision aid 
5 Patient information Preliminary included during face-to-face meeting 
6 Care map Added during face-to-face meeting and preliminary included 
7 Decision box Added during teleconference and preliminary included 
8 Question prompt list Added during teleconference and preliminary included 
   
 Action plan Added during face-to-face meeting, excluded 
 Decision guide Added during face-to-face meeting, excluded 
   
 Care pathway Excluded from list 
 Quality standard Excluded from list 
 Care standard Excluded from list 
 Care module Excluded from list 
 Clinical practice guideline  Excluded from list 
 Protocol  Excluded from list 
 viewpoint Excluded from list 
 
Table 2: overview of preliminary included and excluded tool types during face-to-face meeting and teleconference 
 
From the preliminarily included tools, we deduced and described the possible purpose(s) of the 
tools. The purpose to inform patients was combined with ‘to educate patients’, because the 
emphasis was to make patients knowledgeable. Another reason to extendt the purpose was that 
informing and educating are often used interchangeably. We made a distinction between the 
purposes supporting decision-making, and that of engaging in shared decision-making. Even 
though tools can support decision-making by patient and professional, this does not necessarily 
mean that the tool also promotes shared decision-making. In the end, the listed possible 
purposes were aggregated into four purposes (see table 3):  
• Inform or educate: provide information on the disease/complaint; what its treatment/care 
options are; how it can affect the patient’s life; what the patient can do herself/himself to 
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cope/deal with the disease/complaint and what the expected harms and benefits of treatment 
are. 
• Provide recommendation(s): summarize evidence & provide recommendation(s) – e.g.  
stemming from CPGs – regarding care option(s). 
• Support decision-making: to support decision-making by the patient (and not decision-making 
together with a healthcare professional): provide information on option(s) (including doing 
nothing, watchful waiting); harms and benefits, risks thereof; elicit values, preferences and 
contemplation so that patients can choose the treatment/care or option that suits best. 
• Engage in shared decision-making: invite, stimulate or instruct the patient to decide together 
with healthcare provider on treatment/care.  
When discussing possible purposes, alleviating fear(s), and decreasing decisional conflict were 
mentioned as well. The participants concluded they were outcomes, and were therefore not 
listed as a purpose. Communication was not included as a purpose. To engage patients, or 
exchange knowledge/information with a patient, as a healthcare professional, you need to 
communicate (verbally and non-verbally) with the patient. It is an overarching means, not a 
purpose in itself. 
 
The next step was to identify core elements of the included patient-directed knowledge tool 
types. The participants compared the tool types, identified recurring elements within tool types 
and between tools. Furthermore, on the basis of existing frameworks and taxonomies they 
determined which elements should be included in a tool type (prototypical), even though existing 
examples of those tool types may not include these elements. Mentioned elements were for 
example, (link to) evidence, background on condition, care or treatment options/alternatives, 
burden (and evidence thereof), relative importance of outcomes as different patients may weigh 
importance of outcomes differently (43). Also, possible effects of the tools, such as improving 
the knowledge of the patient, improving patient’s expectations of the treatment, impact on their 
health and quality of life, improving patient-provider communication, and changes in decision-
making behaviour) were discussed as possible purposes. Whilst discussing the elements, 
explicit mentioning of harms and benefits of treatment/care in the tools was stressed by the 
participants. Harms were especially emphasised as these are often not mentioned or mentioned 
less often than benefits (44-46). At the end, the core elements were put into preliminary 
categories.  
 
When discussing the framework, the purposes, and core elements of the tool types, several 
issues surfaced. First, at the beginning of the meeting, one participant stated that the patient-
directed knowledge tools are preferably based on trustworthy clinical practice guidelines. 
However, there appears to be a pivotal point between PDAs and CPGs: the element 
‘recommendation’. A CPG centres on recommendations, meaning that the healthcare 
professional needs to ‘translate’ it together with the patient to the patient characteristics and 
preferences (47), whereas decision aids aim to acquaint patients with information about choices 
and available options, including watchful monitoring. Of late, clinical practice guidelines 
(recommendations) are created or re-written to include these elements as well, but it is not a 
common practice yet (21, 48, 49).   
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As one of the participants involved in the meeting noted: “Looking through a future lens and 
decision making view: [there will be] a set of guidelines that don’t [provide room for 
contemplation], and ‘innovator’ guidelines that do list options.”  
[quote on reconciling clinical practical guidelines and shared decision-making] (50) 
 
Furthermore, some participants argued using other sources than CPGs as a basis for patient-
directed knowledge tools, such as evidence summaries or systematic reviews, and questioned 
how to include qualitative data in the evidence base (51).  
 
We also discussed whether the framework should be discretionary or prototypical. Discretionary 
meaning that the core elements mentioned in the framework are optional; and prototypical 
indicating that we should aim to include the core elements listed in the framework in patient-
directed knowledge tools. For example, current tools mostly disregard core elements such as 
harms and the need to elicit patient’s values (52). Often only one option is stated, instead of 
giving a complete overview of options, including watchful waiting when relevant (44). We 
decided that it would be a descriptive and prototypical framework. 
 
This decision resulted in one participant to say: “We are wasting time on patient education 
material without options; we need to be bold.” [quote on importance of a prototypical framework] 
 
Finalizing the draft framework entailed checking and rewriting the wording used in the 
framework, and reorganizing the core element categories (7, 53-55). The category ‘outcomes’, 
which refers to the effect(s) of the tools, was not included in the framework. Possible effects 
proposed and discussed during the meeting were: improved knowledge acquisition by the 
patient, more realistic or informed expectations, decreased decision burden/stress or less 
regret. As most of these outcomes have not been confirmed by research (yet), we felt it 
premature to include this category in the framework (56). 
 
The draft framework at the end of the meeting contained eight tools (see table 2), of which two – 
‘care map and decision box – were conditionally included as we were not entirely sure if they 
were patient-directed knowledge tools. The framework in the article contains five tool types, 
because when looking further into the tools ‘question prompt list’ and ‘decision box’, we decided 
that these tools belong to the tool type ‘encounter PDAs, and they were therefore removed from 
the framework as separate tool types. The tool type ‘care map’ was left out as well, as they are 
also called ‘care pathways’ (16, 19), and we excluded the latter at the beginning of the meeting. 
It was also suggested in the feedback rounds via email to leave out the tool ‘decision tree’. Due 
to renewed attention to this tool type – e.g. digitalising CPGs into decision trees to enhance use 
by healthcare professionals and patients (57-59), and because the tool was not included 
conditionally as were the tools ‘care map’ and ‘decision box’, it is still part of the draft framework. 
 
The final working draft of the framework contains consists five patient-directed tool types, and 
consists of two parts: one stating the four purposes of the tools (see table 3) and the other the 
core elements (see table 4 (see annex E)).  
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To inform or to educate1 +  + + + 
To provide recommendation(s)2  +  +  
To support decision-making3  + + + + 
 
To engage in SDM4 
 
    + 
 
Table 3: Draft framework part 1: purposes of patient directed knowledge tools 
 
 
4.0 Discussion and conclusion 
4.1 Discussion 
We developed a working (or draft) framework containing five patient-directed knowledge tool 
types describing the purposes and (prototypical) core elements of these tools. There already 
exist other related frameworks; however, these tend to focus on patient decision aids. At the 
other end of the spectrum, the CCCG taxonomies take a far broader view, incorporating all 
interventions for communication without a specific focus on knowledge tools, and without 
delineating the core elements of the interventions (29, 31, 53, 60).  
 
4.2 Conclusions  
As there exists an abundance of different patient-directed knowledge tools, with different names 
and mostly unclear definitions, our working draft framework can help tool developers, people 
who commission the development of these tools, policy makers, patients and healthcare 
professionals to discern between the different tools, and to identify to which tool type it belongs, 
which purposes it serves and which core elements it should contain. Possibly, when there is 
more clarity on development, content and purpose of the tool, it may lead to a better 
understanding of the roles of, and uptake of, the tool. We feel that the field of tools development 
and implementation might profit from initiatives such as this one; it might provide the sought for 
direction and leadership. 
 
Regarding the discussion whether to use only CPGs as basis for patient-directed knowledge 
tools, such as ePDAs, the group discussed the benefits of harmonizing evidence summaries 
across these tools, also within the context of updating content. Such CPGs and accompanying 
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PDAs have been developed, for example within the MAGIC-project, providing proof of concept 
for this approach (37, 49, 61).  
 
New (types of) tools will emerge. We can use these to test our working framework by assessing 
if the new tool fits within the current types, whether it requires adding a new tool type, additional 
purposes or core elements to the framework, or if it is a different type of tool not belonging 
within the framework. 
 
Next steps are to review the framework thoroughly with a broader group of stakeholders, 
including patients and other users. Working with the framework will demonstrate if it is helpful 
and complete regarding tool types, purposes, and core elements. For example, it may be helpful 
to discuss whether or not merging of the last two purposes (support and engage in shared 
decision-making) would be a useful revision to the framework. A first cautious check of the 
framework took place at the International Shared Decision Making (ISDM) Conference, Lyon, in 
2017 (62), meeting general agreement and receiving no major comments with respect to 
content. The framework, a work in progress, could be further enhanced by identifying which 
effect outcomes of the tools are supported by evidence, and describing the core elements in 
more detail. Additionally, it is important to consider the implementation and use of these tools, 
for instance by exploring what skills or support patients need to be able to use them (63).  
 
A potential weakness was the extent to which the participants are involved in this subject. We 
tried to counteract this by having a group consisting of participants with different expertise and 
from various backgrounds, and by providing descriptions of the discussed tools before the 
meeting. Also, the group was limited in its size. Therefore, the framework was not presented as 
finished but as a draft framework. Another risk of the group composition and size could be that it 
obscured tools as not being within scope. There were no patient representatives present during 
the meeting; however, two participants (SH and RR) with extensive experience in health 
consumer participation and patient-centred care commented and added to the work of the group 
at the end of day 1. Having (most of) the participants together for a prolonged time in one room, 
contributed to enhanced participation, open discussions and the liberty to ask each other 
questions, making it possible to respond to non-verbal communication, and leading to a first 
draft of the conceptual framework. 
 
4.3 Implications for practice  
Our working framework on different types of patient-directed knowledge tools is aimed at 
developers, and possibly at those who commission the development of tools, healthcare 
professionals and policy makers, and hopefully adds to provides clarity on the different 
knowledge tools by stating the purpose(s) they serve and which core elements they should 
include. The ambition is that tool types are no longer developed without a clear definition and 
use. This working framework will make it easier for developers to identify when to develop which 
patient-directed knowledge tool and what core elements to include, and to help patients and 
professionals to understand when to use which tool type.   
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Legends 
 
Legend of table 3: Framework part 1: purposes of patient directed knowledge tools: 
 
+ knowledge tool serves purpose 
 
1 To inform or to educate: provide information on the disease/complaint; what its treatment/care options are; how it 
can affect the patient’s life; what the patient can do herself/himself to cope/deal with the disease/complaint and what 
are the expected harms and benefits of treatment. 
2 To provide recommendation(s): summarize evidence & provides recommendation(s) - e.g. stemming from 
guidelines - regarding care option(s).  
3 To support decision making by the patient (and not decision making together with a healthcare professional): 
provide information on option(s) (including doing nothing, watchful waiting); harms and benefits, risks thereof; elicit 
values, preferences and contemplation so that patients can choose the treatment/care or option that suits best. 
Possibly indicate which % of patients in a similar situation chose which option. 
4 To engage in shared decision-making: invite, stimulate or instruct the patient to decide together with healthcare 
provider on treatment/care.  
 
Abbreviations: 
- CPG: clinical practice guideline 
- PDA: patient decision aid  
- SDM: shared decision making 
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Annexes  
Annex A – Meeting protocol 
 
POW(W) – purpose, outcome, why – of meeting 
Purpose Statement of meeting 
objective(s) 
To develop a framework that makes it possible to position 
knowledge and decision support tool types along 3 or 4 
axes/dimensions, next to clarifying their mutual relations. By 
doing so, this framework would help tool developers which tool 
needs to be developed in which case. 
Outcome More specific; it is 
what you have when 
you walk out of the 
door of the meeting, 
the desired result 
A framework to be presented to the knowledge and decision 
support tools community of developers, and, implementers, 
possibly even users, to test whether it is usable and suitable. 
A framework that can be adjusted to the national situation. 
A plan how to ensure that stakeholders worldwide are informed 
about the framework. 
Why The rationale for 
achieving the meeting 
objective(s) and each 
individual’s “what’s in 
it for me” 
To meet a heart-felt need by developers, implementers and users 
of knowledge and decision support tools to clarify the different 
types of tools and how they are mutually related, so that 
developers can develop the right tool for the right job. 
To contribute to the different domains of research of the 
participants, and unifying terminology in and across domains. 
 
Meeting programme 
DAY 1 (Feb 23rd) DAY 2 (Feb 24th) 
8:30 - Welcome 
- Introductions 
- Presentation 
Whole group  
9:00 Reflection & summarizing day 1 
Whole group 
9:00 Reflection on: 
- Scope of invitational (step 1) 
- Assessing list of knowledge tool types 
familiar and complete types (step 2) 
Whole group 
 Fine tuning and finalizing (1): (step 8) 
- Purposes of tools (part 1) 
- Checking/ticking boxes of part 1 of 
framework 
Presentation subgroup results & whole group 
10:30 Coffee break 10:30 Coffee break 
 Sorting exercise: 
- In/excluding knowledge tools (step 3) 
- Identifying purposes of tools (step 4) 
In subgroups 
 Fine tuning and finalizing (2): (step 9) 
- Core ingredients of tools (part 1) 
- Checking/ticking boxes of part 2 of 
framework 
Presentation subgroup results & whole group 
12:30 Lunch break 12:30 Follow-up and next steps 
 Identifying core ingredients (step 5) 
In subgroups 
13:00 Barometer & end of day two 
15:00  Break – preparing material for 
teleconference 
Whole group 
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16:30 Video- and/or teleconference 
Presenting & discussing results of 
invitational so far (step 6) 
- Knowledge tools 
- List of purposes & core ingredients 
- Visual representation of draft 
framework 
Chair and TC participants (60min.), followed 
by discussion (30 min., all) 
18:00 Line-up & end of day one 
Material to be send via email to SH & RR 
(step 7) 
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Annex B – Participants consensus meeting invitational 
 
Country Name Affiliation Background & expertise Role 
Present face-to-face meeting in Leiden 
CAN Jeremy Grimshaw Ottawa Hospital Research Institute General practitioner; knowledge transfer; implementation Chair   
NL Dunja Dreesens Maastricht University, Knowledge Institute of Medical 
Specialists 
Health & social sciences; guidelines; health policy Secretary  
NL Trudy van der 
Weijden 
Maastricht University Epidemiologist; guidelines; SDM; implementation Moderator 
CH Thomas Agoritsas University of Geneva Internal medicine; epidemiologist; evidence-based health care Participant 
USA Glyn Elwyn The Dartmouth Institute for Health Policy and Clinical 
Practice 
General practitioner; SDM; decision aids Participant 
N Signe Flottorp Norwegian Institute of Public Health, University of Oslo General practitioner; health services; chronic disease Participant 
NL Leontien Kremer National Institute for the Quality of Health Care NL Paediatrician; systematic reviews; guidelines; evidence-based 
health care 
Participant 
CAN Nancy Santesso McMaster University Dietician; GRADE; communication to patients/public; guidelines Participant 
CAN Dawn Stacey Ottawa Hospital Research Institute Nurse; systematic reviews; decision aids Participant 
NL Anne Stiggelbout Leiden University Human nutrition; medical decision making; patient preferences; 
costs and benefits 
Participant 
UK Shaun Treweek DECIDE, University of Aberdeen Physicist; health services; trial design Participant 
Participated in teleconference 
USA Melissa Armstrong University of Florida Neurologist; engaging patients; guidelines Participant 
CAN Anna Gagliardi University of Toronto Implementation science, patient-centered care, patient 
engagement 
Participant  
CAN France Légaré Université LAVAL Architect; family physician; implementation; SDM Participant 
N Per Vandvik DECIDE, University of Oslo Physician; evidence-based health care; GRADE; decision 
making 
Participant  
Participated via email 
AUS Sophie Hill* La Trobe University Melbourne, Cochrane Consumers 
and Communication Group 
Health communication and participation; public health; health 
literacy 
Participant 
AUS Rebecca Ryan La Trobe University Melbourne, Cochrane Consumers 
and Communication Group 
Pharmacology & neuroscience; consumer participation; risk 
communication 
Participant 
 
* Sophie Hill was willing to participate in teleconference. However, due to the time difference this proved difficult. 
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Annex D – Tool types and definitions used at the start of the meeting 
 
In a Delphi study in the Netherlands an expert panel reached consensus on the selection and definitions 
of a core set of knowledge and decision support tools primarily used in the care process by patient and / 
or professional (in or outside consultation). 
 
In the grey rows the tool types that were included during the invitational. 
 
Type of 
knowledge tool 
Definition  
Clinical practice 
guideline 
Recommendations for a specific (health) care issue based on 1) a 
systematic summary of scientific research, 2) considerations of the 
advantages and disadvantages of various care options and 3) the 
knowledge and experiences of patients and providers; supports decision-
making in the care process and is aimed at safeguarding and improving 
the quality of life and care 
Included (as 
patient version 
of guideline) 
(1) 
Decision tree/flow 
chart 
Logically structured visualization of possibilities in a (health) care issue 
with associated outcomes, opportunities, risks and decision points; offers 
care providers and patients insight into the relevant care policies and 
supports decision making 
Included (2) 
Summary (of 
guideline) 
Concise overview of the guideline providing main conclusions and 
recommendations in clear and simple language; can be applied in practice 
independently from the guideline; intended for both care providers and 
patients 
excluded 
Protocol  Instruction derived from a guideline, indicating how care providers should 
act in daily practice, within the restraints of specific local circumstances 
excluded 
Patient decision 
aid (PDA) /support 
tool 
Supporting information and answers to frequently asked questions for 
patients when choosing, with their care providers, from different options – 
including the option to forgo care – in areas such as diagnostics, 
treatment, screening, counselling and aftercare; discusses the possible 
outcomes and effects of each option – desirable or otherwise – their 
likelihood to occur; helps patients weigh up their options based on their 
own values, standards and personal circumstances 
Included – and 
split into two: 
encounter PDA 
(3) and 
independent 
PDA (4) 
Patient /client 
information 
Explanation of a specific condition or (health) care issue based on a 
guideline; made available to patients and their next of kin; provides 
information on available care choices and the care they can expect from 
the care process 
Included (5) 
Viewpoint Rules of conduct for a topical and/or delicate (health) care issue; drawn 
up on a fast-track, ad hoc basis by a professional or scientific association 
in collaboration with patients; provides guidance for care providers and 
patients when a guideline is not yet available 
excluded 
Care pathway Guideline-based description of the shared decision-making in the care 
setting regarding the (health) care provided to a patient with a specific 
care need; intended for care providers; aimed at delivering optimal care, 
tailored to the needs of the specific patient 
excluded 
Quality standard*  Description of good care for a specific health-related theme in 
accordance with the Dutch National Health Care Institute’s assessment 
framework; helps to improve and ensure quality of life and care; intended 
for guideline developers 
excluded 
Care standard*  Description of the organization of multidisciplinary care – including 
prevention – for a particular care issue; based on scientifically 
substantiated topical insights; may indicate tasks and be drafted from the 
perspective of the patient; covers in particular support for self-
management; may include performance indicators 
excluded 
Care module*  Description of an item of care relevant to several care issues; can be part 
of multiple care standards; brings into line non-disease-specific care in 
relevant care standards 
excluded 
* Unsure whether these tools are known, and/or used in other countries than the Netherlands 
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Annex E – Framework part 2: core elements of patient directed knowledge tools (table 4) 
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CONTENT ELEMENTS 
Information on disease, illness ✓ ✓ ✓ ✓ +/- 
Eligibility information (describing the target 
group of the tool) 
✓ ✓ ✓ ✓ ✓ 
Treatment & care options identified (including 
wait and see) 
✓ ✓ ✓ ✓ ✓ 
Features of each option (e.g. practical issues, 
process, burden, cost, harms and benefits of 
these options) 
+/- ? ✓ +/- ✓ 
Possible benefits harms of these options +/- ? ✓ +/- ✓ 
Explicit decision(s) identified O ✓ ✓ +/- ✓ 
Personalizing features O ✓ +/- O +/- 
Values implicitly clarified +/- +/- N +/- ✓ 
Values explicitly clarified O O +/- ✓ +/- 
Explicit recommendations O ✓ O ✓ O 
DM process guidance O ✓ +/- O +/- 
 
QUALITY ELEMENTS 
Link to evidence explicit +/- +/-1 ✓ ✓ ✓ 
Grading of evidence described, e.g. GRADE O O +/- +/- +/- 
Date stamp ✓ ✓ ✓ ✓ ✓ 
Certification process / trustworthy source O O P2 O P1 
Stating developers’ conflicts of interests (or 
where to find these) 
✓ ✓ ✓ ✓ ✓ 
Available in clearing house, register O O ✓ +/- ✓ 
 
USE / TIMING OF TOOL 
Independent of consult +/- O +/- +/- O 
Pre-consult ✓ +/- ✓ ✓ +/- 
During consult O +/- +/- O ✓ 
Post-consult +/- O +/- +/- +/- 
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Legend 
✓ Necessary  
+/- Possibly  
O Not typical 
P Present  
? Not known (yet) 
 
1 P (in Netherlands only) 
2 P (in USA only) 
 
Abbreviations: 
- CPG: Clinical practice guideline 
- PDA: patient decision aid 
- DM: decision making 
- GRADE: Grading of Recommendations Assessment, Development and Evaluation 
 
 
 
